News
The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...
23m
Investor's Business Daily on MSNNovo Nordisk Inks A Major Obesity Deal, Sending Shares Of New Partner Septerna SkyrocketingNovo Nordisk inked an obesity deal worth up to $2.2 billion on Wednesday, and sent shares of Septerna into the stratosphere.
European Commission President Ursula von der Leyen has lost a lawsuit attempting to force her to disclose text messages with ...
From my colleague Jason Mast: The first ever patient has been treated with prime editing, a powerful technology for making ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results